GlassScriptPhysician profile
Dawn M Barilli
NPI 1295732196
$999.99
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $762 · 2022: $238.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $402.85 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $115.00 | 2021 | |
| Pfizer INC. | $91.04 | 2021-2022 | |
| Janssen Biotech, INC. | $66.76 | 2021 | |
| Novartis Pharmaceuticals Corporation | $55.58 | 2021-2022 | |
| Lilly USA, LLC | $51.33 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $36.72 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $29.21 | 2021 | |
| Galderma Laboratories, L.P. | $28.56 | 2021 | |
| Incyte Corporation | $19.80 | 2021 | |
| Vyne Pharmaceuticals INC. | $19.78 | 2021 | |
| Journey Medical Corporation | $18.75 | 2022 | |
| Leo Pharma INC. | $17.86 | 2021 | |
| Sun Pharmaceutical Industries INC. | $17.77 | 2022 | |
| Amgen INC. | $17.07 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $11.91 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Barilli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.